https://www.selleckchem.com/pr....oducts/gsk-2837808A.
Infantile-onset inflammatory bowel disease (IO-IBD) occurs in very young children and causes severe clinical manifestations, which has poor responses to traditional inflammatory bowel disease (IBD) treatments. At present, there are no simple and reliable laboratory indicators for early screening IO-IBD patients, especially those in whom the disease is caused by monogenic diseases. To search for valuable indicators for early identifying IO-IBD patients, especially those in whom the disease is caused by monogenic diseases. A retrospe
Like
Comment
Share
